In November 2021, machineMD and CSEM Neuchâtel launched their joint Innosuisse project, which will last 1.5 years.

CSEM is a Swiss private, non-profit research and technology organization with...

MachineMD has successfully closed a financing round of CHF 1.4m. We are developing a diagnostic platform for early detection of neurodegenerative diseases based on eye and pupil movements. The...